Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease

Continuous infusion of levodopa or apomorphine provide constant dopaminergic stimulations are good alternatives to deep brain stimulation to control motor fluctuations in patients with advanced Parkinson’s disease (PD). Apomorphine provides motor benefit similar to dopamine, but its long-term use is...

Full description

Bibliographic Details
Main Author: Angelo Antonini
Format: Article
Language:English
Published: Korean Movement Disorder Society 2009-05-01
Series:Journal of Movement Disorders
Subjects:
Online Access:http://e-jmd.org/upload/jmd-2-1-4-2.pdf
_version_ 1797716057390055424
author Angelo Antonini
author_facet Angelo Antonini
author_sort Angelo Antonini
collection DOAJ
description Continuous infusion of levodopa or apomorphine provide constant dopaminergic stimulations are good alternatives to deep brain stimulation to control motor fluctuations in patients with advanced Parkinson’s disease (PD). Apomorphine provides motor benefit similar to dopamine, but its long-term use is limited by compliance, mostly injection site skin reactions. Administration of levodopa/carbidopa by continuous duodenal infusion allows replacement of all oral medications and permits achievement of a satisfactory therapeutic response paralleled by a reduction in motor complication severity. However, this procedure is more invasive than apomorphine as it requires a percutaneous endoscopic gastrostomy Clinical experience with infusions shows that continuous dopaminergic stimulation of dopaminergic medications reduces dyskinesia and widens the therapeutic window in advanced PD.
first_indexed 2024-03-12T08:15:53Z
format Article
id doaj.art-7f225422f2634d10a6bbd0e14fb20594
institution Directory Open Access Journal
issn 2005-940X
2093-4939
language English
last_indexed 2024-03-12T08:15:53Z
publishDate 2009-05-01
publisher Korean Movement Disorder Society
record_format Article
series Journal of Movement Disorders
spelling doaj.art-7f225422f2634d10a6bbd0e14fb205942023-09-02T18:53:32ZengKorean Movement Disorder SocietyJournal of Movement Disorders2005-940X2093-49392009-05-01214910.14802/jmd.0900290Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s DiseaseAngelo AntoniniContinuous infusion of levodopa or apomorphine provide constant dopaminergic stimulations are good alternatives to deep brain stimulation to control motor fluctuations in patients with advanced Parkinson’s disease (PD). Apomorphine provides motor benefit similar to dopamine, but its long-term use is limited by compliance, mostly injection site skin reactions. Administration of levodopa/carbidopa by continuous duodenal infusion allows replacement of all oral medications and permits achievement of a satisfactory therapeutic response paralleled by a reduction in motor complication severity. However, this procedure is more invasive than apomorphine as it requires a percutaneous endoscopic gastrostomy Clinical experience with infusions shows that continuous dopaminergic stimulation of dopaminergic medications reduces dyskinesia and widens the therapeutic window in advanced PD.http://e-jmd.org/upload/jmd-2-1-4-2.pdfParkinson’s diseaseInfusionApomorphineLevodopaCarbidopaDuodopaDBS
spellingShingle Angelo Antonini
Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
Journal of Movement Disorders
Parkinson’s disease
Infusion
Apomorphine
Levodopa
Carbidopa
Duodopa
DBS
title Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_full Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_fullStr Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_full_unstemmed Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_short Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
title_sort apomorphine and levodopa infusion therapies for advanced parkinson s disease
topic Parkinson’s disease
Infusion
Apomorphine
Levodopa
Carbidopa
Duodopa
DBS
url http://e-jmd.org/upload/jmd-2-1-4-2.pdf
work_keys_str_mv AT angeloantonini apomorphineandlevodopainfusiontherapiesforadvancedparkinsonsdisease